Literature DB >> 646236

Staging laparotomy and splenectomy for Hodgkin's disease.

Y T Lee, R J Lukes, E J Finck, D I Feinstein, D R Powars.   

Abstract

The major objective of diagnostic laparotomy in Hodgkin's disease is to define the extent of involvement not detectable by nonoperative means. Fifty patients in this institution had operative staging procedures; six for recurrent disease three to 11 years after initial therapy. Twenty-four patients had nodular sclerosis, 23 mixed cellularity, and three had other types. The clinical stages were advanced in 13 patients and decreased in seven patients. Two patients (both had mixed cellularity and systemic symptoms) had positive wedge biopsy of the liver, whereas direct needle biopsy was negative. Nineteen spleens contained Hodgkin's disease but only three could be palpated on physical examination. About half the patients with abnormal lymphangiograms had positive periaortic nodes; lymphangiogram had a false negative rate of 12%. Additional procedures performed included appendectomy, oophoropexy, and resection of Meckel's diverticulum. There was no mortality and only one case had severe postoperative Salmonella septicemia. Our findings are comparable with those reported in the literature.

Entities:  

Mesh:

Year:  1978        PMID: 646236

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

Review 1.  The role of the spleen in leukemias and lymphomas including Hodgkin's disease.

Authors:  R Maurer
Journal:  Experientia       Date:  1985-02-15

2.  Staging laparotomy in Hodgkin's disease.

Authors:  J M Sterchi; R T Myers
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

3.  Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion.

Authors:  Y T Lee
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

4.  Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial.

Authors:  J Askergren; M Björkholm; G Holm; B Johansson; H Mellstedt; R Sundblad; G Söderberg
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.